RESUMEN
INTRODUCTION: Gastric cancer (GC) is the first cause of cancer-related death in Chile and 6th in Latin America and the Caribbean (LAC). Helicobacter pylori (H. pylori) is the main gastric carcinogen, and its treatment reduces GC incidence and mortality. Esophageal-gastro-duodenoscopy (EGD) allows for the detection of premalignant conditions and early-stage GC. Mass screening programs for H. pylori infection and screening for premalignant conditions and early-stage GC are not currently implemented in LAC. The aim of this study is to establish recommendations for primary and secondary prevention of GC in asymptomatic standard-risk populations in Chile. METHODS: Two on-line synchronous workshops and a seminar were conducted with Chilean experts. A Delphi panel consensus was conducted over 2 rounds to achieve>80% agreement on proposed primary and secondary prevention strategies for the population stratified by age groups. RESULTS: 10, 12, and 12 experts participated in two workshops and a seminar, respectively. In the Delphi panel, 25 out of 37 experts (77.14%) and 28 out of 52 experts (53.85%) responded. For the population aged 16-34, there was no consensus on non-invasive testing and treatment for H. pylori, and the use of EGD was excluded. For the 35-44 age group, non-invasive testing and treatment for H. pylori is recommended, followed by subsequent test-of-cure using non-invasive tests (stool antigen test or urea breath test). In the ≥45 age group, a combined strategy is recommended, involving H. pylori testing and treatment plus non-invasive biomarkers (H. pylori IgG serology and serum pepsinogens I and II); subsequently, a selected group of subjects will undergo EGD with gastric biopsies (Sydney Protocol), which will be used to stratify surveillance according to the classification Operative Link for Gastritis Assessment (OLGA); every 3 years for OLGA III-IV and every 5 years for OLGA I-II. CONCLUSION: A "test-and-treat" strategy for H. pylori infection based on non-invasive studies (primary prevention) is proposed in the 35-44 age group, and a combined strategy (serology and EGD) is recommended for the ≥45 age group (primary and secondary prevention). These strategies are potentially applicable to other countries in LAC.
RESUMEN
BACKGROUND: Bioaccumulation of toxic metals in the population is associated with adverse health effects. Although some elements are essential for humans, high levels of exposure can be dangerous. OBJECTIVE: To describe the levels of Inorganic Arsenic (AsIn), Cadmium (Cd), Chromium (Cr), and Mercury (Hg) in urine, and Lead (Pb) in blood in the population of Arica, Chile. METHODOLOGY: Descriptive study. Beneficiaries of the Health Surveillance Program of Law 20.590 in sites of higher risk of exposure in the commune of Arica were considered eligible. The results of biological samples to measure their concentrations of AsIn, Cd, Cr, Hg in urine, and Pb in blood between August 2016 and May 2021 are described. RESULTS: 9520 samples from a population with a mean age of 40.5 years were studied. 4.21% of the adult population and 6.57% of the children had AsIn values above 35 µg/L, while at least 95 % of the total samples had levels below 33 µg/L. At least 90 % of the samples had Cd levels below 1.1 µg/L, and 8.44 % had Cd levels above 2 µg/L, higher in males (11.67%). There were no values above the reference in children. 99.77% and 99.33% had Cr and Pb values below the reference limit, respectively (using the lowest reference range established by Chile Ministry of Health (MINSAL) < 5 µg/L). Children did not present risk values for Cr, and 0.16% presented Pb concentrations between 5-10 µg/dL. All samples presented Hg concentrations below risk levels (< 10 µg/L). CONCLUSIONS: The results of this study suggest that a small percentage of the samples analyzed in the beneficiary population of Arica register metal concentration levels above national reference levels established by MINSAL, mainly AsIn, Cd, and Pb. It is essential to continue biomonitoring to reduce and prevent exposure to these metals, which can have harmful effects on human health.
Asunto(s)
Cadmio , Exposición a Riesgos Ambientales , Plomo , Mercurio , Humanos , Chile , Masculino , Adulto , Femenino , Niño , Plomo/sangre , Plomo/análisis , Exposición a Riesgos Ambientales/análisis , Exposición a Riesgos Ambientales/efectos adversos , Persona de Mediana Edad , Cadmio/análisis , Cadmio/sangre , Cadmio/orina , Adolescente , Adulto Joven , Mercurio/análisis , Mercurio/sangre , Mercurio/orina , Arsénico/análisis , Arsénico/orina , Arsénico/sangre , Preescolar , Metales Pesados/análisis , Metales Pesados/sangre , Metales Pesados/orina , Anciano , Cromo/análisis , Cromo/sangre , Cromo/orina , Monitoreo del Ambiente , LactanteRESUMEN
INTRODUCTION: Gastric cancer (GC) is one of the most lethal malignancies worldwide. Helicobacter pylori is the primary cause of GC; therefore, its eradication reduces the risk of developing this neoplasia. There is extensive evidence regarding quadruple therapy with relevance to the European population. However, in Latin America, data are scarce. Furthermore, there is limited information about the eradication rates achieved by antibiotic schemes in European and Latin American populations. OBJECTIVE: To compare the effectiveness of standard triple therapy (STT), quadruple concomitant therapy (QCT), and bismuth quadruple therapy (QBT) in six centers in Europe and Latin America. METHODS: A retrospective study was carried out based on the LEGACy registry from 2017 to 2022. Data from adult patients recruited in Portugal, Spain, Chile, Mexico, and Paraguay with confirmed H. pylori infection who received eradication therapy and confirmatory tests at least 1 month apart were included. Treatment success by each scheme was compared using a mixed multilevel Poisson regression, adjusting for patient sex and age, together with country-specific variables, including prevalence of H. pylori antibiotic resistance (clarithromycin, metronidazole, and amoxicillin), and CYP2C19 polymorphisms. RESULTS: 772 patients were incorporated (64.64% females; mean age of 52.93 years). The total H. pylori eradication rates were 75.20% (255/339) with STT, 88.70% (159/178) with QCT, and 91.30% (191/209) with QBT. Both quadruple therapies (QCT-QBT) showed significantly higher eradication rates compared with STT, with an adjusted incidence risk ratio (IRR) of 1.25 (p: <0.05); and 1.24 (p: <0.05), respectively. The antibiotic-resistance prevalence by country, but not the prevalence of CYP2C19 polymorphism, showed a statistically significant impact on eradication success. CONCLUSIONS: Both QCT and QBT are superior to STT for H. pylori eradication when adjusted for country-specific antibiotic resistance and CYP2C19 polymorphism in a sample of individuals residing in five countries within two continents.
RESUMEN
BACKGROUND: Bioaccumulation of toxic metals in the population is associated with adverse health effects. Although some elements are essential for humans, high levels of exposure can be dangerous. OBJECTIVE: To describe the levels of Inorganic Arsenic (AsIn), Cadmium (Cd), Chromium (Cr), and Mercury (Hg) in urine, and Lead (Pb) in blood in the population of Arica, Chile. METHODOLOGY: Descriptive study. Beneficiaries of the Health Surveillance Program of Law 20.590 in sites of higher risk of exposure in the commune of Arica were considered eligible. The results of biological samples to measure their concentrations of AsIn, Cd, Cr, Hg in urine, and Pb in blood between August 2016 and May 2021 are described. RESULTS: 9520 samples from a population with a mean age of 40.5 years were studied. 4.21% of the adult population and 6.57% of the children had AsIn values above 35 μg/L, while at least 95 % of the total samples had levels below 33 μg/L. At least 90 % of the samples had Cd levels below 1.1 μg/L, and 8.44 % had Cd levels above 2 μg/L, higher in males (11.67%). There were no values above the reference in children. 99.77% and 99.33% had Cr and Pb values below the reference limit, respectively (using the lowest reference range established by Chile Ministry of Health (MINSAL) < 5 μg/L). Children did not present risk values for Cr, and 0.16% presented Pb concentrations between 5-10 μg/dL. All samples presented Hg concentrations below risk levels (< 10 μg/L). CONCLUSIONS: The results of this study suggest that a small percentage of the samples analyzed in the beneficiary population of Arica register metal concentration levels above national reference levels established by MINSAL, mainly AsIn, Cd, and Pb. It is essential to continue biomonitoring to reduce and prevent exposure to these metals, which can have harmful effects on human health.
ANTECEDENTES: La bioacumulación de metales en la población está asociada a efectos adversos y pueden ser peligrosos. OBJETIVO: Describir los niveles de Arsénico Inorgánico (AsIn), Cadmio (Cd), Cromo (Cr), Mercurio (Hg) y Plomo (Pb) en la población de Arica, Chile. MATERIALES Y MÉTODOS: Estudio descriptivo. Se incluyeron todas las personas beneficiarias del Programa de Vigilancia de Salud de la Ley 20.590 en sitios de riesgo de mayor exposición en la comuna de Arica entre agosto 2016 y mayo 2021. RESULTADOS: Se estudiaron 9.520 muestras provenientes de una población con una edad media de 40.5 años. 4.21% de la población adulta y el 6.57% de los niños presentaron valores de AsIn superiores a 35 μg/L y al menos el 95% de las muestras totales tenía niveles inferiores a 33 μg/L. Más del 90 % de las muestras tuvieron niveles de Cd menores a 1.1 μg/L y un 8.44% registró niveles de Cd superiores 2 μg/L. El 99.77% y 99.33% exhibieron valores normales de Cr y Pb, respectivamente. Todas las muestras presentaron concentraciones de Hg por debajo de los niveles de riesgo (< 10 μg/L). CONCLUSIONES: Los resultados sugieren que un porcentaje pequeño de la población de Arica registra niveles de concentración de metales por sobre niveles de referencia nacional establecidos por el Ministerio de Salud de Chile, principalmente de AsIn, Cd y Pb. Es importante continuar con la vigilancia para reducir y prevenir la exposición a estos metales, que pueden generar efectos nocivos en la salud humana.
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Adulto Joven , Cadmio/análisis , Cadmio/orina , Cadmio/sangre , Exposición a Riesgos Ambientales/análisis , Exposición a Riesgos Ambientales/efectos adversos , Plomo/análisis , Plomo/sangre , Mercurio/análisis , Mercurio/orina , Mercurio/sangre , Arsénico/análisis , Arsénico/orina , Arsénico/sangre , Chile , Monitoreo del Ambiente , Cromo/análisis , Cromo/orina , Cromo/sangre , Metales Pesados/análisis , Metales Pesados/orina , Metales Pesados/sangreRESUMEN
Objetivo: explorar la siguiente pregunta de investigación: ¿De qué manera el nivel socioeconómico de una persona, específicamente el nivel de pobreza se asocia a las características de las exposiciones agudas a sustancias con potencial tóxico en Chile? Métodos: estudio epidemiológico, de diseño transversal y semi-ecológico. Se recopiló información proveniente de una muestra de casos atendidos por el Centro de información toxicológica y de medicamentos de la Pontificia Universidad Católica de Chile (CITUC). La variable independiente corresponde al índice de pobreza comunal de la Encuesta de Caracterización Socioeconómica Nacional (CASEN). Las variables dependientes fueron las características de las exposiciones registradas por el centro toxicológico de acuerdo con el nivel de pobreza de los casos observados. Se analizó el fenómeno a través de tablas cruzadas, cálculo de Odds Ratio con análisis estratificado. Resultados: se observan diferencias significativas en las circunstancias de las exposiciones: las personas que viven en comunas con mayor porcentaje de pobreza muestran más exposiciones intencionales versus aquellas con menor porcentaje de pobreza. Otro hallazgo significativo es el uso del sistema de salud en casos de exposiciones dependiente de la situación socioeconómica. Para las otras variables no se encuentran diferencias significativas entre los grupos comparados. Conclusio-nes: se observa una relación entre el nivel de pobreza y las exposiciones a sustancias potencialmente tóxicas. Los resultados abren una línea investigativa y nuevas interrogantes que podrían generar medidas de control de las intoxicaciones en Chile.Palabras clave:toxicología; exposición a compuestos químicos; envenenamiento; determinantes sociales de la saludAbstractObjective: explore the following research question: How is a person's socio-economic level, the poverty, associated with the characteristics of acute exposures to substances with toxic potential in Chile?. Methods: epidemiological, cross-sectional and semi-ecological study. Information collected from a sample of cases attended by the Centre for Toxicological and Drug Information of the Pontifical Catholic University of Chile (CITUC). The independent variable corresponds to the communal poverty index of the National Socioeconomic Characterization Survey. Dependent variables were the characteristics of the exposures recorded by the toxicological center according to the poverty level of the cases observed. The phenomenon is analyzed through cross-tables, calculating Odds Ratios with stratified analysis. Results: significant differences observed in the circumstances of exposures: people living in communes with higher poverty rates show more intentional exposures versus those with lower poverty rates. Another significant finding is the use of the health system in cases of exposures, depending on the socio-economic situation. For the other variables, there are no significant differences between the compared groups. Conclusions: there is a link between the poverty level and acute exposures to potentially toxic substances. The results open a research line and new questions that could generate measures to control poisonings in Chile.Keywords:poisoning; social determinants of health; poverty(1) Centro de Información Toxicológica y de Medicamentos, Pontificia Universidad Católica de Chile.(2) Unidad docente de Farmacología y Toxicología, Facultad de Medicina, Pontificia Universidad Católica de Chile.(3) Departamento de Salud del Adulto y Senescente, Escuela de Enfermería, Pontificia Universidad Católica de Chile.(4) Departamento de Laboratorios Clínicos, Facultad de Medicina, Pontificia Universidad Católica de Chile.(5) Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile.Autor de correspondencia: Juan Carlos Ríos jriosb@uc.clFecha de envío: 19 de agosto de 2019 - Fecha de aceptación: 26 de diciembre de 2019